alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.7

                                 PROMISSORY NOTE

Executed at Houston, Texas
Dated:  August 14, 2000
Principal Sum:  $1,080,712

FOR ADVANCES RECEIVED, from time to time over the years since 1993, totaling as
of June 30, 2000 the principal sum shown above, REDOX TECHNOLOGY CORPORATION, a
Delaware corporation with principal offices located at 340 N. Sam Houston
Parkway East, Houston, Texas 77070 promises to pay the to the order of RICHARD
A. SZYMANSKI (hereinafter "Lender") the principal sum set forth above on or
before December 21, 2000 (hereinafter "Maturity Date").

The loan represented by this Promissory Note shall initially bear no interest to
December 31, 2000; however, if this Promissory Note is not paid, in full on or
before the Maturity Date, interest shall be retroactively be applicable for the
period from the date hereof to the Maturity Date at the rate of ten percent
(10%) per annum, simple interest from the date hereof. If Borrower fails to pay
the full amount of principal together with the interest thereon on the date it
becomes due, Borrower shall be in default. The unpaid principal and the unpaid
interest thereon retroactively calculated shall thereafter both bear interest at
the rate of eighteen percent (18%) per annum until paid; but this provision
shall not increase the liability of Borrower beyond the legal interest rate. If
any law, which applies to this loan and which sets maximum loan charges, is
finally interpreted so that the interest or other loan charges to be collected
in connection with this loan exceed permitted limits, then this loan shall not
be void but any such interest or loan charge shall be reduced by the amount
necessary to reduce such collection ,including reasonable attorney fees in case
payment is not mace when it becomes due. Presentiment, notice of dishonor, and
protest are hereby waived by the Borrower. This note is to be construed and
enforced in accordance wither he laws of the State of Texas, in existence on the
date of this Promissory Note.

IN WITNESS WHEREOF, intending to be legally bound, the Borrower has executed
this Promissory Note as of the date above written.

                          REDOX TECHNOLOGY CORPORATION

                                                By: /S/ RICHARD SZYMANSKI
                                                    -------------------------
                                                    Richard A. Szymanski

ATTEST:

/S/ CLIFTON D. DOUGLAS
----------------------
Clifton D. Douglas, Treasurer
Exhibit 32.1

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18,
United States Code), each of the undersigned officers of Kraton Performance Polymers, Inc. and Kraton Polymers LLC, a Delaware limited liability company ( together, the Registrants), does hereby certify, to such officers knowledge,
that:

The Annual Report on Form 10-K for the fiscal year ended December 31, 2009 (Form 10-K) of the
Registrant fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations
of the Company.

Dated: March 15, 2010



By:

/s/    KEVIN M.
FOGARTYKevin M. FogartyChief Executive OfficerBy:

/s/    STEPHEN E.
TREMBLAYStephen E. TremblayChief Financial Officer
|                                                                                                             
|-------------------------------------------------------------------------------------------------------------
|                                                                                                             
|View History: Annual Download Data (XLS File)                                                               
|View History: Annual                                                                                         
|View History: Annual                                                                                         
|View History:                                                                                                
|                                                                                                             
|Louisiana--South Onshore Natural Gas Liquids Lease Condensate, Proved Reserves Acquisitions (Million Barrels)
|                                                                                                             
|                                                                                                             
|Louisiana--South Onshore Natural Gas Liquids Lease Condensate, Proved Reserves Acquisitions (Million Barrels)
|                                                                                                             

|Decade                                                                                                                            | Year-0 | Year-1 | Year-2 | Year-3 | Year-4 | Year-5 | Year-6 | Year-7 | Year-8 | Year-9
|--------------------------------------------------------------------------------------------------------------------------------- | ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------
|2000's                                                                                                                            |        |        |        |        |        |        |        |        |        | 1     
|2010's                                                                                                                            | 5      | 7      | 1      | 6      | 4      | 5      | 1      | 4      | 0      | 1     
|2020's                                                                                                                            | 4      | 0      |        |        |        |        |        |        |        |       
|- = No Data Reported;  -- = Not Applicable;  NA = Not Available;  W = Withheld to avoid disclosure of individual company data.
|                                                                                                                                 
|Release Date: 12/30/2022                                                                                                         
|Next Release Date: 12/29/2023
Michigan Supreme Court

Lansing, Michigan

Stephen J. Markman, Chief Justice

Brian K. Zahra

Bridget M. McCormack

David F. Viviano 

Richard H. Bernstein

Kurtis T. Wilder

Elizabeth T. Clement, Justices

I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

 December 4, 2018

p1126

Order 

Clerk

December 4, 2018

157502

PEOPLE OF THE STATE OF MICHIGAN, 

Plaintiff-Appellee,

v SC: 157502

COA: 335843

Lapeer CC: 15-012331-FH

RICHARD CHARLES MALLORY,

Defendant-Appellant. 

_________________________________________/

On order of the Court, the application for leave to appeal the March 13, 2018 

judgment of the Court of Appeals is considered, and it is DENIED, because we are not 

persuaded that the questions presented should be reviewed by this Court.
Exhibit 32.1
 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  1.
    
    The Periodic Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and2.
    
    The information contained in the Periodic Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
 Date: November 7, 2008

/s/ RICHARD L. LANGLEYRichard L. Langley, Chief Executive OfficerDate: November 7, 2008

/s/ JOSEPH S. LERCZAKJoseph S. Lerczak, Chief Financial Officer
Prepared by MERRILL CORPORATION





Exhibit 10.10


[BIOTRANSPLANT LOGO]


Building
75, 3rd
Avenue

Charlestown Navy Yard

Charlestown, MA 02129

Tel: 617/241-5200

Fax: 612/241-8780


November 13, 1991


Richard V. Capasso

39 Rocky Nook

Malden, MA 02148


Dear Rick:


This letter will confirm our offer to you
to join BioTransplant, Inc. on the following terms:


	Title:	Controller
	 	 
	Terms:	This
  offer is contingent on your starting on or about December 9, 1991.
	 	 
	Compensation:	$65,000
  per year/six month review, no guarantee of salary increase.
	 	 
	Bonus:	Eligible;
  with a guaranteed minimum of $5,000 for 1992.
	 	 
	Equity:	10,000
  options; subject to approval by the Board of Directors.
	 	 
	Agreements:	Your
  employment is subject to your signing a Confidentiality, Invention Agreement
  and a Non-Compete Agreement with BioTransplant and review of any agreement
  you may have with others to insure that your employment with BioTransplant is
  not in conflict with any such agreements.



If these terms are acceptable, please
sign and return one copy of this agreement.


We look forward to your joining the
company and sharing in our new challenge.


Best regards,


/s/ Elliot Lebowitz

Elliot Lebowitz, Ph.D.

President and C.E.O


AGREED TO:


	By:  	/s/
  Richard V. Capasso	 	Date:	11/14/91
	 	

	 	 	


	 	Richard
  V. Capasso	 	 	 



 





[BIOTRANSPLANT LOGO]


Building
75, 3rd
Avenue

Charlestown Navy Yard

Charlestown, MA 02129

Tel: 617/241-5200

Fax: 612/241-8780


March
31, 1996


Mr. Richard Capasso

10 Rolling Lane

Wayland, MA 01778


Dear Rick:


             Reference
is made to the Letter Agreement dated November 13, 1991, by and between
BioTransplant Incorporated and you (the “Letter Agreement”).  The Letter Agreement is hereby amended to
add the following additional term:


	 	Severance:	In
  the event your employment is terminated without cause, you will receive up to
  6 months base salary, payable in 12 equal installments which will be
  discontinued upon your securing other employment.



             Please
sign below to acknowledge your agreement with the foregoing.


	 	Very
  truly yours,
	 	 
	 	/s/
  Elliot Lebowitz
	 	


	 	Elliot
  Lebowitz, Ph.D.
	 	President
  and Chief Executive Officer



AGREED:


	By:	/s/
  Richard V. Capasso
	 	


	 	Richard
  V. Capasso



Date: 
April 15, 1996
ASSIGNMENT

WHEREAS  International Medical Associates, Inc., of Miami, Florida, is the owner
of  the  entire  right, title and interest in and to the following United States
Letters  Patent:

     Patent  No:                    Patent  Date
     -----------                    ------------

     5,336,213                      August  9,  1994


and  the  inventions  therein  described;

AND  WHEREAS, Americare Technologies, Inc., a Florida Corporation doing business
at  20  N.W.  181st  Street,  Miami, Florida 33169, is desirous of acquiring the
entire  interest  in  said  invention, and in said United States Letters Patent;

NOW  THEREFORE,  be it known that for and in consideration of a contract between
International  Medical  Associates,  Inc., and Americare Technologies, Inc., and
other  valuable  consideration,  the  receipt and sufficiency whereof are hereby
acknowledged;  International  Medical  Associates,  Inc.  has sold, assigned and
transferred, and by these presence does sell, assign and transfer unto Americare
Technologies,  Inc., its legal representatives, successors and assigns, the full
and  exclusive  rights to the said invention as fully set forth and described in
the  above-mentioned  Letters  Patent  of  the  United  States,  and any and all
reissues  of  said  Letters Patent, the same to be held and enjoyed by Americare
Technologies,  Inc.,  its legal  representatives, successors and assigns, to the
full  end  of  the term for which said Letters Patent has been granted or may be
reissued  or  extended,  as  fully and entirely the same would have been held by
International  Medical  Associates,  Inc., had this Assignment and sale not been
made.

IN  TESTIMONY  WHEREOF,  we have hereunto set our hands and seals this 23 day of
June,  1997.

                               International Medical Associates, Inc.


                               By:  /s/  Joseph P. D'Angelo           (LS)
                                  ------------------------------------
                                  Dr.  Joseph  P.  D'Angelo
                                  President


<PAGE>
Exhibit 32.1**Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350,Chapter 63 of Title 18, United States Code)**Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350,chapter 63 of title 18, United States Code), each of the undersigned officers of Kraton PolymersLLC, a Delaware limited liability company (the “Registrant”), does hereby certify, to suchofficer’s knowledge, that:The Annual Report on Form 10-K for the fiscal year ended December 31, 2007(“Form 10-K”) of theRegistrant fully complies with the requirements of section 13(a) or 15(d) of the SecuritiesExchange Act of 1934 and information contained in the Form 10-K fairly presents, in all materialrespects, the financial condition and results of operations of the Company.Dated:March 31, 2008         By:         /s/ Kevin M. Fogarty    Kevin M. Fogarty    Chief Executive Officer       By:         /s/ Stephen E. Tremblay    Stephen E. Tremblay    Chief Financial Officer
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4898 Introduced in House (IH)]

112th CONGRESS
  2d Session
                                H. R. 4898

To suspend temporarily the duty on certain women's footwear with outer 
soles and uppers of rubber or plastics and valued over $12 but not over 
                             $20 per pair.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 26, 2012

 Mr. Carnahan introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
To suspend temporarily the duty on certain women's footwear with outer 
soles and uppers of rubber or plastics and valued over $12 but not over 
                             $20 per pair.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. CERTAIN WOMEN'S FOOTWEAR WITH OUTER SOLES AND UPPERS OF 
              RUBBER OR PLASTICS AND VALUED OVER $12 BUT NOT OVER $20 
              PER PAIR.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00        Footwear with       Free            No change      No change      On or before     ''.
                          outer soles and                                                   12/31/2015
                          uppers of rubber
                          or plastics,
                          covering the
                          ankle, valued
                          over $12 but not
                          over $20/pair,
                          other than tennis
                          shoes, basketball
                          shoes, gym shoes,
                          training shoes,
                          or the like, for
                          women, other than
                          work footwear
                          (provided for in
                          subheading
                          6402.91.90)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
##### 



Exhibit 10.38
 Consent and Second Amendment  to  Loan and Security Agreement
 CONSENT AND SECOND AMENDMENT SILICON VALLEY BANK EV3
ENDOVASCULAR, INC. EV3 INTERNATIONAL, INC. MICRO THERAPEUTICS, INC. Borrowers th
 Recitals
 A.
 B.
 C.
 D.
 Agreement
 Now, Therefore,
 1. Definitions.




---



##### 



2. Consent to Merger.
 3. New Co-Borrower.
 a.
 b.
 c.
 d.
 4. Amendments to Loan Agreement.
 4.1 Section 6.7(b) (Tangible Net Worth Covenant)
 2




---



##### 



4.2 Section 7.3 (Mergers or Acquisitions).
 5. Limitation of Amendments.
 5.1
 5.2
 6. Representations and Warranties.
 6.1
 6.2
 3




---



##### 



6.3
 6.4
 6.5
 6.6
 6.7
 7. Counterparts.
 8. Effectiveness
 4




---



##### 



In Witness Whereof,
 Borrowers:EV3 ENDOVASCULAR, INC.
    
    
    
    EV3 INTERNATIONAL, INC.By
    
    /s/ Patrick D. Spangler
    
    
    
    By
    
    /s/ Patrick D. SpanglerName:
    
    Patrick D. Spangler
    
    
    
    Name:
    
    Patrick D. SpanglerTitle:
    
    Vice President and
    
    
    
    Title:
    
    TreasurerChief Financial OfficerMICRO THERAPEUTICS, INC.By
    
    /s/ Patrick D. SpanglerName:
    
    Patrick D. SpanglerTitle:
    
    Chief Financial Officer
and TreasurerBank:SILICON VALLEY BANKBy
    
    /s/ Jay McNeilName:
    
    Jay McNeilTitle:
    
    Senior Relationship
Manager
 5
#### KENNEBREW v. STATE.

No. 23125.

Court of Criminal Appeals of Texas.

June 20, 1945.

Irwin & Irwin, of Dallas, for appellant.

Ernest S. Goens, State’s Atty., of Austin, for the State.

KRUEGER, Judge.

Appellant was convicted of the offense of burglary and his punishment was assessed at confinement in the penitentiary for a period of two years.

The only question presented for review relates to the court’s action in overruling appellant’s motion to quash the indictment in this case on the ground that the court excused one of the prospective grand jurors and directed the bailiff to summon one, P. A. Bailey, as a prospective grand juror to fill the place of the one who was excused. The evidence on the issue of whether the court directed the bailiff to summon Mr. Bailey or whether the bailiff summoned him on his own judgment and volition is very much in conflict. This issue the trial court, in the exercise of his judicial discretion, decided adversely to appellant, and his judgment in the matter is binding on this court, unless it clearly appears that he abused his discretion with respect thereto. We do not deem it necessary to enter upon an extended discussion of the question as the exact point regarding this same grand juror was before this court in the case of Turner v. State, decided April 4, 1945, but not yet reported [in State Reports], and was thoroughly discussed in that case. For the reason therein stated, we overrule appellant’s contention.

From what we have said, it follows that the judgment of the trial court should be affirmed, and it is so ordered.

PER CURIAM.

The foregoing opinion of the Commission of Appeals has been examined by the Judges of the Court of Criminal Appeals and approved by the Court.
* Pursuant to 5TH CIR. R. 47.5, the court has determined

that this opinion should not be published and is not precedent

except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 00-20981

Conference Calendar

 

PATRICK WASHINGTON,

Plaintiff-Appellant,

versus

TOMMY THOMAS; ET AL.,

 Defendants,

TOMMY THOMAS,

Defendant-Appellee.

- - - - - - - - - -

Appeal from the United States District Court

for the Southern District of Texas

USDC No. H-99-CV-102

- - - - - - - - - -

June 18, 2001

Before WIENER, DeMOSS, and DENNIS, Circuit Judges.

PER CURIAM:*

Patrick Washington, Texas prisoner #888936, appeals the

dismissal of his 42 U.S.C. § 1983 complaint for failure to state

a claim upon which relief may be granted. 

Washington’s motion for appointment of counsel is DENIED.

Washington contends that the defendants were deliberately

indifferent to his serious medical needs by failing to provide
No. 00-20981

-2-

him with a CPAP (continuous positive airway pressure) machine for

his sleep apnea. Neither his complaint nor his Spears hearing

testimony reflects that Washington suffered substantial harm as a

result of not receiving CPAP treatment. Thus, whatever

deficiencies there may have been in Williams’s treatment, if any,

certainly do not rise to the level of establishing deliberate

indifference on the part of the defendants. See Mendoza v.

Lynaugh, 989 F.2d 191, 195 (5th Cir. 1993). Accordingly, the

district court did not err in dismissing his complaint for

failure to state a claim. 

Washington’s appeal is without merit and therefore

frivolous. See Howard v. King, 707 F.2d 215, 219-20 (5th Cir.

1983). Because the appeal is frivolous, it is DISMISSED. See

5TH CIR. R. 42.2. The district court’s dismissal of the present

case and our dismissal of this appeal count as two strikes

against Washington for purposes of 28 U.S.C. § 1915(g). We

caution Washington that once he accumulates three strikes, he may

not proceed in forma pauperis in any civil action or appeal filed

while he is incarcerated or detained in any facility unless he is

under imminent danger of serious physical injury. See 28 U.S.C.

§ 1915(g). 

APPEAL DISMISSED; SANCTION WARNING ISSUED.
`
 

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

 

In connection with the annual report of Midnight Candle Company (the "Company") on Form 10-KSB for the year ended December 31, 2007, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Helen C. Cary, acting in the capacity as the Chief Executive Officer and Patrick Deparini, acting in the capacity as the Principal Financial Officer of the Company, certify to the best of our knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)  The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange

      Act of 1934; and

 

(2)  The information contained in the Report fairly presents, in all material respects, the financial condition

      and result of operations of the Company.

 

 

/s/ Helen C. Cary

     Helen C. Cary

     Chief Executive Officer

     March 10, 2008

 

 

 

/s/Patrick Deparini

    Patrick Deparini

    Principal Financial Officer

    March 10, 2008

 

 

 
`
----

----

III Oznámení

Komise

----

VYHLÁŠENÍ VÝBĚROVÉHO ŘÍZENÍ NA MÍSTO MÍSTOPŘEDSEDY ODRŮDOVÉHO ÚŘADU SPOLEČENSTVÍ

(platová třída A*12)

(čl. 29 odst. 2 služebního řádu)

KOM/2006/10022

(2006/C 83 A/01)

Odrůdový úřad Společenství hledá pracovníka na pozici místopředsedy úřadu.

Uchazeči musejí být občany některého z členských států Evropské unie.

Místopředsedu jmenuje Rada ze seznamu kandidátů, které navrhne Komise po konzultaci se správní radou úřadu. Platové a pracovní podmínky odpovídají podmínkám stanoveným pro úředníky Evropských společenství třídy A*12 ve služebním řádu. Odrůdový úřad Společenství a Komise uplatňují politiku rovných příležitostí.

Popis pracovní náplně, přihlášky a pokyny k zasílání přihlášek je možné získat na těchto internetových adresách:

Uzávěrka pro přijímání přihlášek je 8. května 2006 (viz podrobnosti v pokynech k přihlášce).

----